血液・腫瘍内科について

HOME > 血液・腫瘍内科について > 業績

業績

2010

原著

Seki R, Ohshima K, Fujisaki T, Uike N, Kawano F, Gondo H, Makino S, Eto T, Moriuchi Y, Taguchi F, Kamimura T, Tsuda H, Shimoda K, Okamura T.
Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab.
Annals of Oncology: 21: 833-841, 2010
Nagafuji K, Matsuo K, Teshima T, Mori S, Sakamaki H, Hidaka M, Ogawa H, Kodera Y, Kanda Y, Maruta A, Mori T, Yoshiba F, Ichinohe T, Kasai M, Takatsuka Y, Kubo K, Sao H, Atsuta Y, Suzuki R, Yoshida T, Tsuchida M, Harada M.
Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry.
Int J Hematol. 2010;91:855-864.
Seki R, Ohshima K, Nagafuji K, Fujisaki T, Uike N, Kawano F, Gondo H, Makino S, Eto T, Moriuchi Y, Taguchi F, Kamimura T, Tsuda H, Ogawa R, Shimoda K, Yamashita K, Suzuki K, Suzushima H, Tsukazaki K, Higuchi M, Utsunomiya A, Iwahashi M, Imamura Y, Tamura K, Suzumiya J, Yoshida M, Abe Y, Matsumoto T, Okamura T.
Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan: a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group.
Int J Hematol 91: 258-266, 2010
Wada H, Hatada T, Okamoto K, Uchiyama T, Kawasugi K, Mayumi T, Gando S, Kushimoto S, Seki Y, Madoiwa S, Okamura T, Toh C H.
Modified non-overt DIC diagnostic criteria predict the early phase of overt-DIC.
Am J Hematol 2010 85:691-694.
Numata A, Miyamoto T, Ohno Y, Kamimura T, Kamezaki K, Tanimoto T, Takase K, Henzan H, Kato K, Takenaka K, Fukuda T, Harada N, Nagafuji K, Teshima T, Akashi K, Harada M, Eto T.
Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: retrospective analysis of the experience of the Fukuoka BMT group.
Bone Marrow Transplant. 2010;45:311-316.
Mori Y, Miyamoto T, Nagafuji K, Kamezaki K, Yamamoto A, Saito N, Kato K, Takenaka K, Iwasaki H, Harada N, Abe Y, Teshima T, Akashi K.
High incidence of human herpes virus 6-associated encephalitis/myelitis following a second unrelated cord blood transplantation.
Biol Blood Marrow Transplant. 2010;16:1596-1602.
Oku S, Takenaka K, Kuriyama T, Shide K, Kumano T, Kikushige Y, Urata S, Yamauchi T, Iwamoto C, Shimoda HK, Miyamoto T, Nagafuji K, Kishimoto J, Shimoda K, Akashi K.
JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activation.
Br J Haematol. 2010;150:334-344.
Takamatsu Y, Sunami K, Hata H, Nagafuji K, Choi I, Higuchi M, Uozumi K, Masaki Y, Tamura K, Kyushu Hematology Organization for Treatment Study G.
A phase I study of bortezomib in combination with doxorubicin and intermediate-dose dexamethasone (iPAD therapy) for relapsed or refractory multiple myeloma.
Int J Hematol. 2010;92:503-509.

症例報告

Morinaga Y, Yanagihara K, Masunaga K, Hashiguchi M, Okamura T, Watanaba H, Kohno S, Kamihira S.
Invasive pneumococcal disease in a traveler who returned from the Philippines: A case report and in vitro study of the Isolate.
J Travel Med 17: 63-65, 2010
Mori Y, Aoki T, Takenaka K, Yamauchi T, Yamamoto A, Kamezaki K, Iwasaki H, Harada N, Miyamoto T, Nagafuji K, Teshima T, Akashi K.
Successful treatment of refractory advanced nasal NK/T cell lymphoma with unrelated cord blood stem cell transplantation incorporating focal irradiation.
Int J Hematol. 2010;91:107-111.
Aoki T, Kamezaki K, Miyamoto T, Nagafuji K, Mori Y, Yamauchi T, Takenaka K, Iwasaki H, Harada N, Shimono N, Teshima T, Akashi K.
Cord Blood stem cell transplantation in a patient with disseminated mucormycosis and acute myelogenous leukemia.
Transpl Infect Dis 12(3):227-9 2010
血液・腫瘍内科について
教授あいさつ
スタッフ
沿革
研究紹介
業績
  • 患者さんへ
  • 医療関係者の方へ
久留米大学医学部 内科学講座
血液・腫瘍内科部門
〒830-0011
福岡県久留米市旭町67
TEL:0942-31-7852
FAX:0942-31-7854
  • 久留米大学 セカンドオピニオン外来
  • 久留米大学
  • 久留米大学病院